Raphamin

Last updated

Raphamin is a drug developed as an antiviral. [1] [2] [3] [4] It is manufactured by the Russian company Materia Medica. [5]

References

  1. ↑ Petrova, N. V.; Emelyanova, A. G.; Tarasov, S. A.; Aparin, P. G.; Ledov, V. A. (September 2023). "Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study". Bulletin of Experimental Biology and Medicine. 175 (5): 649–652. doi:10.1007/s10517-023-05919-7. PMID   37861906. S2CID   264348443.
  2. ↑ Khamitov, Rustem F.; Nikiforov, Vladimir V.; Zaytsev, Andrey A.; Tragira, Irina N. (15 January 2022). "Evaluation of the efficacy and safety of a complex antiviral drug based on antibodies in the treatment of adult patients with acute respiratory viral infection". Terapevticheskii Arkhiv. 94 (1): 83–93. doi: 10.26442/00403660.2022.01.201345 . PMID   36286922.
  3. ↑ Petrova, N. V.; Emelyanova, A. G.; Tarasov, S. A.; Glubokova, е. а.; Каrtashova, N. P. (December 2022). "Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection". Bulletin of Experimental Biology and Medicine. 174 (2): 250–253. doi: 10.1007/s10517-023-05683-8 . PMC   9812737 . PMID   36600043.
  4. ↑ Ganina, K. K.; Petrova, N. V.; Tarasov, S. A.; Epstein, O. I. (May 2023). "Combined Drug with Antibacterial Effect Supports the Normal Intestinal Microflora". Bulletin of Experimental Biology and Medicine. 175 (1): 37–40. doi:10.1007/s10517-023-05806-1. PMID   37338753. S2CID   259201686.
  5. ↑ "Инструкция по применению препарата Рафамин". rafamin.ru. Retrieved 12 November 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.